Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: US Preventive Services Task Force Recommendation Statement
Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: US Preventive Services Task Force Recommendation Statement
复制标题
DOI：
10.7326/m14-1884
复制
发表时间：
2014-12-02
影响因子：
39.2
通讯作者：
LeFevre, Michael L.
中科院分区：
文献类型：
--
作者：
LeFevre, Michael L.
描述：1996年美国预防服务工作组(USPSTF)关于孕期预防阿司匹林的建议的更新。方法：USPSTF审查了关于低剂量阿司匹林在预防高危妇女先兆子痫和减少不利的孕产妇和围产期健康后果方面有效性的证据，并评估了怀孕期间服用小剂量阿司匹林对母婴的伤害。人口：这项建议适用于无症状的孕妇，她们患先兆子痫的风险增加，并且以前没有使用小剂量阿司匹林的不良反应或禁忌症。建议：USPSTF建议在怀孕12周后使用低剂量阿司匹林(81 mg/d)作为预防药物，对妊娠12周的高危孕妇进行预防。(B)建议)
Description: Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy.Methods: The USPSTF reviewed the evidence on the effectiveness of low-dose aspirin in preventing preeclampsia in women at increased risk and in decreasing adverse maternal and perinatal health outcomes, and assessed the maternal and fetal harms of low-dose aspirin during pregnancy.Population: This recommendation applies to asymptomatic pregnant women who are at increased risk for preeclampsia and who have no prior adverse effects with or contraindications to low-dose aspirin.Recommendation: The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. (B recommendation)